Evidence map›Paper›PMID 22941880›Full record

ArticleEuropean respiratory review : an official journal of the European Respiratory Society2012

Global effort against rare and orphan diseases.

Sergio Harari, Vincent Cottin, Marc Humbert

Abstract readEditorial
In one paragraph

Article in European respiratory review : an official journal of the European Respiratory Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Rare pulmonary disease and orphan drugs: a path to the future.European respiratory review : an official journal of the European Respiratory Society · 2019
    Article
  4. Severe idiopathic pulmonary fibrosis: what can be done?European respiratory review : an official journal of the European Respiratory Society · 2017
    Review
  5. Rare pulmonary diseases: a common fight.European respiratory review : an official journal of the European Respiratory Society · 2017
    Article
  6. Rare pulmonary diseases and orphan drugs: where do we stand and where are we going to?European respiratory review : an official journal of the European Respiratory Society · 2015
    Article
  7. Future perspectives on rare pulmonary diseases and rare presentations of common disorders.European respiratory review : an official journal of the European Respiratory Society · 2013
    Article
  8. You say goodbye, and I say hello!European respiratory review : an official journal of the European Respiratory Society · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sergio Harari
Vincent Cottin
Marc Humbert

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cooperative BehaviorGlobal HealthInternational CooperationOrphan Drug ProductionCongresses as TopicHumansLung DiseasesPrognosisRare DiseasesTranslational Research, Biomedical

Identifiers

PMID22941880
PMCPMC9487339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.